News
Pays $10m for rights to targeted immunotherapy product
PPD opens new research lab in Athlone and Warner Chilcott establishes HQ in Dundalk
Philipp Rösler says industry has a monopolistic hold over the country
Bristol-Myers Squibb and AstraZeneca prepare phase IV trial for their diabetes treatment
Gains MS and cancer candidates through Facet Biotech deal
Staff take to the streets over decision to shut Verona R&D facility
A round-up of pharma manufacturing developments from Strides Arcolab, Stirling Products, NextPharma, Dishman, SAFC Pharma and many more
Merial and Intervet/Schering-Plough to be unified into one business
